Exelixis
EXEL
#1822
Rank
NZ$19.41 B
Marketcap
NZ$76.42
Share price
-2.41%
Change (1 day)
22.19%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company